Tailored-dose chemotherapy with gemcitabine and irinotecan in patients with platinum-refractory/resistant ovarian or primary peritoneal cancer: a phase II trial.

Published in: Journal of gynecologic oncology (2020)

UMIN Clinical Trials Registry Identifier: UMIN000004449.

Keyphrases